← Scroll for more →
Metagenomi Therapeutics, Inc. (MGX)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.80
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.99
P/B Ratio
0.27
Institutional Ownership
16.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.08M | $1.0M | 2.85% | +19.8K | 2026-06-30 |
| Renaissance Technologies LLC | 742.4K | -- | 1.97% | -45.5K | 2026-06-30 |
| Catalio Capital Management, LP | 529.0K | -- | 1.40% | -- | 2026-06-30 |
| Peapod Lane Capital LLC | 525.0K | -- | 1.39% | +8.3K | 2026-06-30 |
| Two Sigma Investments, LP | 513.7K | -- | 1.36% | -- | 2026-06-30 |
| Bridgeway Capital Management, LLC | 400.3K | -- | 1.06% | +4.5K | 2026-06-30 |
| Wells Fargo & Company | 379.5K | -- | 1.00% | +177.4K | 2026-06-30 |
| Geode Capital Management, LLC | 288.7K | -- | 0.76% | -69.5K | 2026-06-30 |
| Pura Vida Investments, LLC | 264.4K | -- | 0.70% | -- | 2026-06-30 |
| BlackRock, Inc. | 257.6K | -- | 0.68% | +27.5K | 2026-06-30 |